Cargando…
Osteoarthritis, mobility-related comorbidities and mortality: an overview of meta-analyses
AIMS: The objective of this review was to examine the relationship between osteoarthritis (OA) and mobility-related comorbidities, specifically diabetes mellitus (DM) and cardiovascular disease (CVD). It also investigated the relationship between OA and mortality. METHODS: An overview of meta-analys...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768583/ https://www.ncbi.nlm.nih.gov/pubmed/33488786 http://dx.doi.org/10.1177/1759720X20981219 |
_version_ | 1783629190413680640 |
---|---|
author | Constantino de Campos, Gustavo Mundi, Raman Whittington, Craig Toutounji, Marie-Josée Ngai, Wilson Sheehan, Brendan |
author_facet | Constantino de Campos, Gustavo Mundi, Raman Whittington, Craig Toutounji, Marie-Josée Ngai, Wilson Sheehan, Brendan |
author_sort | Constantino de Campos, Gustavo |
collection | PubMed |
description | AIMS: The objective of this review was to examine the relationship between osteoarthritis (OA) and mobility-related comorbidities, specifically diabetes mellitus (DM) and cardiovascular disease (CVD). It also investigated the relationship between OA and mortality. METHODS: An overview of meta-analyses was conducted by performing two targeted searches from inception to June 2020. The association between OA and (i) DM or CVD (via PubMed and Embase); and (ii) mortality (via PubMed) was investigated. Meta-analyses were selected if they included studies that examined adults with OA at any site and reported associations between OA and DM, CVD, or mortality. Evidence was synthesized qualitatively. RESULTS: Six meta-analyses met inclusion criteria. One meta-analysis of 20 studies demonstrated a statistically significant association between OA and DM, with pooled odds ratio of 1.41 (95% confidence interval: 1.21, 1.65; n = 1,040,175 patients). One meta-analysis of 15 studies demonstrated significantly increased risk of CVD among OA patients, with a pooled risk ratio of 1.24 (1.12, 1.37, n = 358,944 patients). Stratified by type of CVD, OA was shown to be associated with increased heart failure (HF) and ischemic heart disease (IHD) and reduced transient ischemic attack (TIA). There was no association reported for stroke or myocardial infarction (MI). Three meta-analyses did not find a significant association between OA (any site) and all-cause mortality. However, OA was found to be significantly associated with cardiovascular-related death across two meta-analyses. CONCLUSION: The identified meta-analyses reported significantly increased risk of both DM and CVD (particularly, HF and IHD) among OA patients. It was not possible to confirm consistent directional or causal relationships. OA was found to be associated with increased mortality, but mostly in relation to CVD-related mortality, suggesting that further study is warranted in this area. |
format | Online Article Text |
id | pubmed-7768583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-77685832021-01-21 Osteoarthritis, mobility-related comorbidities and mortality: an overview of meta-analyses Constantino de Campos, Gustavo Mundi, Raman Whittington, Craig Toutounji, Marie-Josée Ngai, Wilson Sheehan, Brendan Ther Adv Musculoskelet Dis Review AIMS: The objective of this review was to examine the relationship between osteoarthritis (OA) and mobility-related comorbidities, specifically diabetes mellitus (DM) and cardiovascular disease (CVD). It also investigated the relationship between OA and mortality. METHODS: An overview of meta-analyses was conducted by performing two targeted searches from inception to June 2020. The association between OA and (i) DM or CVD (via PubMed and Embase); and (ii) mortality (via PubMed) was investigated. Meta-analyses were selected if they included studies that examined adults with OA at any site and reported associations between OA and DM, CVD, or mortality. Evidence was synthesized qualitatively. RESULTS: Six meta-analyses met inclusion criteria. One meta-analysis of 20 studies demonstrated a statistically significant association between OA and DM, with pooled odds ratio of 1.41 (95% confidence interval: 1.21, 1.65; n = 1,040,175 patients). One meta-analysis of 15 studies demonstrated significantly increased risk of CVD among OA patients, with a pooled risk ratio of 1.24 (1.12, 1.37, n = 358,944 patients). Stratified by type of CVD, OA was shown to be associated with increased heart failure (HF) and ischemic heart disease (IHD) and reduced transient ischemic attack (TIA). There was no association reported for stroke or myocardial infarction (MI). Three meta-analyses did not find a significant association between OA (any site) and all-cause mortality. However, OA was found to be significantly associated with cardiovascular-related death across two meta-analyses. CONCLUSION: The identified meta-analyses reported significantly increased risk of both DM and CVD (particularly, HF and IHD) among OA patients. It was not possible to confirm consistent directional or causal relationships. OA was found to be associated with increased mortality, but mostly in relation to CVD-related mortality, suggesting that further study is warranted in this area. SAGE Publications 2020-12-25 /pmc/articles/PMC7768583/ /pubmed/33488786 http://dx.doi.org/10.1177/1759720X20981219 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Constantino de Campos, Gustavo Mundi, Raman Whittington, Craig Toutounji, Marie-Josée Ngai, Wilson Sheehan, Brendan Osteoarthritis, mobility-related comorbidities and mortality: an overview of meta-analyses |
title | Osteoarthritis, mobility-related comorbidities and mortality: an
overview of meta-analyses |
title_full | Osteoarthritis, mobility-related comorbidities and mortality: an
overview of meta-analyses |
title_fullStr | Osteoarthritis, mobility-related comorbidities and mortality: an
overview of meta-analyses |
title_full_unstemmed | Osteoarthritis, mobility-related comorbidities and mortality: an
overview of meta-analyses |
title_short | Osteoarthritis, mobility-related comorbidities and mortality: an
overview of meta-analyses |
title_sort | osteoarthritis, mobility-related comorbidities and mortality: an
overview of meta-analyses |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768583/ https://www.ncbi.nlm.nih.gov/pubmed/33488786 http://dx.doi.org/10.1177/1759720X20981219 |
work_keys_str_mv | AT constantinodecamposgustavo osteoarthritismobilityrelatedcomorbiditiesandmortalityanoverviewofmetaanalyses AT mundiraman osteoarthritismobilityrelatedcomorbiditiesandmortalityanoverviewofmetaanalyses AT whittingtoncraig osteoarthritismobilityrelatedcomorbiditiesandmortalityanoverviewofmetaanalyses AT toutounjimariejosee osteoarthritismobilityrelatedcomorbiditiesandmortalityanoverviewofmetaanalyses AT ngaiwilson osteoarthritismobilityrelatedcomorbiditiesandmortalityanoverviewofmetaanalyses AT sheehanbrendan osteoarthritismobilityrelatedcomorbiditiesandmortalityanoverviewofmetaanalyses |